Adenosine A2a Receptor antibody (N-Term)
Quick Overview for Adenosine A2a Receptor antibody (N-Term) (ABIN2774274)
Target
See all Adenosine A2a Receptor (ADORA2A) AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- N-Term
-
Sequence
- SFAIGLTPML GWNNCGQPKE GKNHSQGCGE GQVACLFEDV VPMNYMVYFN
-
Predicted Reactivity
- Dog: 86%, Human: 100%, Rabbit: 85%, Rat: 79%
-
Characteristics
- This is a rabbit polyclonal antibody against ADORA2A. It was validated on Western Blot.
-
Purification
- Affinity Purified
-
Immunogen
- The immunogen is a synthetic peptide directed towards the N terminal region of human ADORA2A
-
-
-
-
Application Notes
- Optimal working dilutions should be determined experimentally by the investigator.
-
Comment
-
Antigen size: 412 AA
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- Lot specific
-
Buffer
- Liquid. Purified antibody supplied in 1x PBS buffer with 0.09 % (w/v) sodium azide and 2 % sucrose.
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handling Advice
- Avoid repeated freeze-thaw cycles.
-
Storage
- -20 °C
-
Storage Comment
- For short term use, store at 2-8°C up to 1 week. For long term storage, store at -20°C in small aliquots to prevent freeze-thaw cycles.
-
-
- Adenosine A2a Receptor (ADORA2A)
-
Alternative Name
- ADORA2A
-
Background
-
ADORA2A is one of several receptor subtypes for adenosine. The activity of the protein, a G-protein coupled receptor family member, is mediated by G proteins which activate adenylyl cyclase. ADORA2A is abundant in basal ganglia, vasculature and platelets and it is a major target of caffeine.
Alias Symbols: ADORA2, RDC8, hA2aR
Protein Interaction Partner: NAMPT, Actn1, Actn4, Actn3, Actn2, ADORA2A, CYTH2, DRD2, ADA,
Protein Size: 412 -
Molecular Weight
- 45 kDa
-
Gene ID
- 135
-
NCBI Accession
- NM_000675, NP_000666
-
UniProt
- P29274
-
Pathways
- Neurotrophin Signaling Pathway, cAMP Metabolic Process, Synaptic Membrane, Feeding Behaviour, Cancer Immune Checkpoints
Target
-